Tumor placentário diagnosticado durante a gravidez: relato de caso

Filho, Francisco Mauad; Costa, Antônio Gadelha da; Spara, Patrícia; Ferreira, Ana Carolina; Júnior, Reginaldo Antônio de Oliveira Freitas; Sala, Maria Matheus de; Valeri, F.

doi:10.1590/s0100-72032002000700009

Cited by 4 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Placental chorioangioma is a placental tumor, which is usually benign. This neoplasm, when consuming the nutrition and oxygenation destined, in theory, to the fetus, can cause the appearance of generalized edema and, therefore, characterizing a picture of NIHFsee the extensive cardiac overload (Mauad Filho et al 2002).…”

Section: Placental Disordersmentioning

confidence: 99%

Fetal hydropsia: challenges in etiologies

Dantas

Santos

Cano

et al. 2021

RSD

View full text Add to dashboard Cite

Introduction: Fetal hydrops is defined as the presence of abnormal fluid collections in two or more extravascular fetal compartments and body cavities. There are about 150 different underlying causes known today potentially leading to this fetal alteration. Objective: To analyze the etiologies involved in the occurrence of cases of fetal hydrops. Methods: A systematic literature review was carried out using the MedLine, Pubmed and Scielo databases, from 2015 to 2021, using the expressions: "fetal, hydrop, etiologies." Discussion: Fetal hydrops is divided into immune and non-immune. Immune results from anemia secondary to erythroblastosis by alloimmunization, so when there is maternal exposure to fetal antigens, it generates an immune response that results in the production of antibodies. History of blood transfusions, previous births, trauma and a history of alloimmunization are characterized as risk factors. Thus, immunoprophylaxis with anti-D immunoglobulin is indicated for all RhD negative pregnant women, with RhD positive male partner, with abundant fetal maternal hemorrhage during childbirth or events with potential sensitizer in the prenatal period. Conclusion: For an effective treatment, it is essential to identify the type of fetal hydrops in the patient and then the etiology of the disease, which is quite variable in Non-Immune Fetal Hydrops.

show abstract

Section: Placental Disordersmentioning

confidence: 99%

Fetal hydropsia: challenges in etiologies

Dantas

Santos

Cano

et al. 2021

RSD

View full text Add to dashboard Cite

show abstract

Giant chorioangioma of the placenta

García-Flores¹,

Vega-Malagón²,

Vega-Malagón³

2005

Intl J Gynecology & Obste

View full text Add to dashboard Cite

A rare case of intra-uterine blood transfusion for fetal anemia caused by a giant placental chorioangioma

Raviv

Shrim

Eidel

et al. 2020

Case Reports in Perinatal Medicine

View full text Add to dashboard Cite

Objectives Chorioangiomas (CAs) are the most frequent tumor-like-lesions of the placenta. Giant CAs (more than 4–5 cm in diameter) is rare and may result in severe maternal fetal complications. Case presentation A 38-year-old multigravida presented at 31 weeks’ gestation with contractions. Upon evaluation, contractions were spontaneously ceased, and the cervix was closed. Ultrasound examination revealed a single viable fetus, polyhydramnios and a 75 x 48 x 82 mm vascular lesion located on the placental surface near the cord insertion. Doppler assessment was suggestive of fetal anemia with middle cerebral artery-peak systolic velocity (MCA-PSV) 1.8 MoM’s. Fetal heart rate monitoring and biophysical scores were reassuring. Following betamethasone fetal cord sampling that revealed fetal hemoglobin level of 8.8 g/dL, 57 cc of blood was transfused resulting in final hemoglobin level of 14.3 g/dL measured prior to needle extraction. MCA-PSV was normalized immediately after the procedure, however aggravated at the following day with MCA-PSV 65 cm/s (1.46 MoM’s). No other intervention was taken and MCA-PSV continued to fluctuate from slight to severe anemia spontaneously over a period of two weeks. At 34 gestational weeks, the women delivered a healthy baby. Fetal hemoglobin level at delivery was 21 g/dL. Conclusions Fetal blood transfusion is a reasonable treatment for fetal anemia in cases of giant chorioangiomas. Following transfusion, MCA-PSV may act unexpectedly reflecting various mechanisms affecting the flow.

show abstract

Tumor placentário diagnosticado durante a gravidez: relato de caso

Cited by 4 publications

References 9 publications

Fetal hydropsia: challenges in etiologies

Fetal hydropsia: challenges in etiologies

Giant chorioangioma of the placenta

A rare case of intra-uterine blood transfusion for fetal anemia caused by a giant placental chorioangioma

Contact Info

Product

Resources

About